Eli Lilly is set to report Q1 earnings on May 1. Analysts predict strong growth, but margin pressures and guidance revisions ...

The future for GLP-1RA compounders, steps pharma can take in light of rising trial costs, funding ultra-rare therapies, and ...

U.S. multinational activity propelled the Irish economy to 3.2% growth in the first quarter, as Trump fears come into focus.

Growth stocks often don't come cheap, especially when their prospects look great, as is the case with Eli Lilly ( LLY 1.09%).

Over the past several decades, epidemiologic studies have documented declines in sperm count and quality. During the same ...

Shares of online health platform Hims & Hers Health soared Tuesday after the company announced a partnership with Novo ...

From a fundamental standpoint, Eli Lilly presently has a market capitalization of $789 billion. Over the trailing twelve ...

A judge denied compounders' request to keep making off-brand Wegovy and Ozempic after the FDA removed semaglutide from its shortage list.

On Friday, Mad Money host Jim Cramer took a close look at what he called one of the most important stretches of the earnings ...

"Ozempic feet" and "Ozempic mouth" are the latest reported cosmetic side effects from GLP-1 medications used for weight loss.

Medications taken for weight loss are starting to impact wedding planning — and perhaps nothing more than the dress fitting.

All these drugs are very effective and they’ve become a game changer for people who need to lose weight. Get on the drug, eat ...